Department of Obstetrics and Gynecology, Centre Hospitalier Intercommunal, Faculté de médecine de Créteil UPEC - Paris XII, 40 Avenue de Verdun, 94000, Créteil, France.
Department of Obstetrics and Gynecology, Hopital Nord, APHM, Marseilles, France.
J Transl Med. 2018 Nov 26;16(1):326. doi: 10.1186/s12967-018-1703-4.
The prognostic impact of surgical paraaortic staging remains unclear in patients with locally advanced cervical cancer (LACC). The objective of our study was to evaluate the survival impact of surgical staging in patients with LACC and no evidence of paraaortic lymph node (PALN) metastasis on pre-operative imaging work-up.
Data of 1447 patients with cervical cancer treated between 1996 and 2016 were extracted from maintained databases of 10 French University hospitals. Patients with locally advanced disease (IB2 or more) treated by concurrent chemoradiation therapy (CRT) and no evidence of paraaortic metastasis on pre-operative imaging work-up were selected for further analysis. The Kaplan-Meier method was used to estimate the survival distribution. A Cox proportional hazards model was used to account for the influence of multiple variables.
Six hundred and forty-seven patients were included, 377 (58.3%) with surgical staging and 270 (41.7%) without, with a mean follow up of 38.1 months (QI 13.0-56.0). Pathologic analysis revealed positive lymph nodes in 47 patients (12.5%). In multivariate model analysis, surgical staging remained an independent prognostic factor for DFS (OR 0.64, CI 95% 0.46-0.89, p = 0.008) and OS (OR 0.43, CI 95% 0.27-0.68, p < 0.001). The other significant parameter in multivariate analysis for both DFS and OS was treatment by intracavitary brachytherapy (OR respectively of 0.7 (0.5-1.0) and 0.6 (0.4-0.9), p < 0.05).
Nodal surgical staging had an independent positive impact on survival in patients with LACC treated with CRT with no evidence of metastatic PALN on imaging.
在局部晚期宫颈癌(LACC)患者中,外科解剖性腹膜后淋巴结分期的预后影响仍不清楚。本研究的目的是评估在影像学检查未见腹膜后淋巴结(PALN)转移的 LACC 患者中,外科分期对生存的影响。
从 10 家法国大学医院的数据库中提取了 1996 年至 2016 年期间治疗的 1447 例宫颈癌患者的数据。选择局部晚期疾病(IB2 期或更晚)患者,接受同期放化疗(CRT)治疗,且影像学检查未见腹膜后转移,进行进一步分析。采用 Kaplan-Meier 法估计生存分布。采用 Cox 比例风险模型来考虑多个变量的影响。
共纳入 647 例患者,其中 377 例行外科分期,270 例未行,中位随访时间为 38.1 个月(QI 13.0-56.0)。病理分析发现 47 例(12.5%)淋巴结阳性。多变量模型分析显示,外科分期仍是 DFS(OR 0.64,95%CI 0.46-0.89,p=0.008)和 OS(OR 0.43,95%CI 0.27-0.68,p<0.001)的独立预后因素。多变量分析中DFS 和 OS 的另一个显著参数是腔内近距离放疗(分别为 OR 0.7(0.5-1.0)和 0.6(0.4-0.9),p<0.05)。
对于影像学检查未见转移性 PALN 的 CRT 治疗的 LACC 患者,淋巴结外科分期对生存有独立的积极影响。